Literature DB >> 10992463

Defective induction of interleukin-12 in human monocytes by germ-tube forms of Candida albicans.

P Chiani1, C Bromuro, A Torosantucci.   

Abstract

Yeast (Y) to germ-tube (GT) transition of Candida albicans is considered a putative virulence trait. On the other hand, interleukin-12 (IL-12) is a key promoter of T-helper type 1 protective immunity against this human opportunistic pathogen. We studied IL-12 production by human monocytes cocultured in vitro with Y or GT forms of C. albicans. Following stimulation by Y cells, monocytes produced appreciable levels of IL-12, which, upon addition of gamma interferon (IFN-gamma), compared to those achievable by lipopolysaccharide (100 ng/ml) stimulation (140 +/- 65 and 185 +/- 80 pg/ml, respectively [mean +/- standard deviation in four independent experiments]). In contrast, IL-12 production by GT cell-stimulated monocytes was much lower or absent (<5 pg/ml) and could not be brought to the level induced by Y cells by the addition of IFN-gamma (30 +/- 10 pg/ml in the four independent experiments above). Besides being observed as actual cytokine production, this lower response was also observed as specific IL-12 p40 mRNA transcript and was not associated with hyperproduction of the IL-12-competing cytokine IL-10. Phagocytosis and killing experiments in the presence of cytochalasin D showed that IL-12 production by Y cell-stimulated monocytes was phagocytosis dependent and that GT cells of C. albicans were not phagocytized by the human monocytes. Importantly, however, Y and GT cells were equally killed by the monocytes. Thus, the virulence trait attributed to the Y-GT transition of C. albicans might also be related to the lack of induction by GT cells of a protective anticandidal immunity through defective IL-12 production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992463      PMCID: PMC101515          DOI: 10.1128/IAI.68.10.5628-5634.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.

Authors:  L Pitzurra; R Cherniak; M Giammarioli; S Perito; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  Putative virulence factors of Candida albicans.

Authors:  J E Cutler
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

3.  The role of recombinant murine IL-12 and IFN-gamma in the pathogenesis of a murine systemic Candida albicans infection.

Authors:  L M Lavigne; L R Schopf; C L Chung; R Maylor; J P Sypek
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

4.  Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells.

Authors:  A Sartori; X Ma; G Gri; L Showe; D Benjamin; G Trinchieri
Journal:  Methods       Date:  1997-01       Impact factor: 3.608

5.  Variability in expression of cell surface antigens of Candida albicans during morphogenesis.

Authors:  D L Brawner; J E Cutler
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

Review 6.  Interleukin-12 and its role in the generation of TH1 cells.

Authors:  G Trinchieri
Journal:  Immunol Today       Date:  1993-07

Review 7.  Candida pathogenesis: unravelling the threads of infection.

Authors:  B E Corner; P T Magee
Journal:  Curr Biol       Date:  1997-11-01       Impact factor: 10.834

8.  CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.

Authors:  L Romani; A Mencacci; E Cenci; R Spaccapelo; P Mosci; P Puccetti; F Bistoni
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

9.  Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.

Authors:  J E Leigh; C Steele; F L Wormley; W Luo; R A Clark; W Gallaher; P L Fidel
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-12-01

10.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.

Authors:  A D'Andrea; M Aste-Amezaga; N M Valiante; X Ma; M Kubin; G Trinchieri
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  13 in total

1.  Deletion of the two-component histidine kinase gene (CHK1) of Candida albicans contributes to enhanced growth inhibition and killing by human neutrophils in vitro.

Authors:  Antonella Torosantucci; Paola Chiani; Flavia De Bernardis; Antonio Cassone; Jose Antonio Calera; Richard Calderone
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production.

Authors:  Meagan W Moore; Adriana R Cruz; Carson J LaVake; Amanda L Marzo; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

Review 3.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

4.  Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.

Authors:  C Retini; T R Kozel; D Pietrella; C Monari; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.

Authors:  Donatella Pietrella; Rosanna Mazzolla; Patrizia Lupo; Lucia Pitzurra; Maria Jesus Gomez; Robert Cherniak; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 6.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

8.  Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis.

Authors:  Brad Spellberg; Douglas Johnston; Quynh Trang Phan; John E Edwards; Samuel W French; Ashraf S Ibrahim; Scott G Filler
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction.

Authors:  Ok S Shin; Ralph R Isberg; Shizuo Akira; Satoshi Uematsu; Aruna K Behera; Linden T Hu
Journal:  Infect Immun       Date:  2008-03-31       Impact factor: 3.441

10.  Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: a novel dimorphism-dependent mechanism to escape the host's immune response.

Authors:  Antonella Torosantucci; Giulia Romagnoli; Paola Chiani; Annarita Stringaro; Pasqualina Crateri; Sabrina Mariotti; Raffaela Teloni; Giuseppe Arancia; Antonio Cassone; Roberto Nisini
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.